However, it is inevitable that drug resistance develops after 10 months of medication, and some experiments have demonstrated that EGFR resistance achieves tumor escape by up-regulating PD-L1 expression (Figure 1) and inhibiting T cells (Peng et al., 2019). The gene discussed is CD274; the disease is neoplasm.